Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study to Evaluate the Safety and Efficacy of IW-1973 in Patients With Type 2 Diabetes With Albuminuria Treated With Renin-Angiotensin System Inhibitors

NCT03217591 is registered in ClinicalTrials.gov with Akebia Therapeutics as lead sponsor.

NCT NCT03217591
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03217591 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study to Evaluate the Safety and Efficacy of IW-1973 in Patients With Type 2 Diabetes With Albuminuria Treated With Renin-Angiotensin System Inhibitors
Lead sponsor
Akebia Therapeutics
Phase
Phase 2
Overall status
Completed
Start date
August 1, 2017
Completion date
August 20, 2019
Enrollment
156 (actual)
Sites
54

Conditions

As the registry lists them; a condition with its own page is linked.

type 2 diabetes mellitus with diabetic nephropathy